Causal relationship between neuropathy and prolonged linezolid use [3]

Clinical Infectious Diseases

Volumn 39, Issue 3, 2004, Pages 439-

  Frippiat, F ^a   Derue, G ^a  

^a Centre Hospitalier Jolimont Lobbes   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; LINEZOLID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

DISEASE COURSE; HUMAN; INTRAOCULAR HYPERTENSION; KNEE PROSTHESIS; KNEE SURGERY; LETTER; NEUROPATHY; NEUROTOXICITY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROSTHESIS INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT FAILURE;

EID: 3943102110     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/422147     Document Type: Letter

References (6)

1. Lee E, Burger S, Shah J, et al. Linezolid associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis 2003; 37:1389-91.
2. Frippiat F, Bergiers C, Michel C, Dujardin J-P, Derue G. Severe bilateral optic neuritis associated with prolonged linezolid therapy. J Antimicrob Chemother 2004; 53:1114-5.
3. Zyvox (linezolid) [package insert]. Rydaimere, New South Wales : Pharmacia Australia, 2002.
4. Birmingham MC, Rayner CR, Meagher AK, et al. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis 2003; 36:159-68.
5. Snavely SR; Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984; 101: 92-104.
6. Ciprofloxacin. In: Kucers A, Crowe SM, Grayson ML, Hoy JP, eds. The use of antibiotics, a clinical review of antibacterial, antifungal and antiviral drugs. 5nd ed. Oxford, UK: Butterworth-Heinemann, 1997:981-1060.